The results of this study have shown increased serum concentration of galectin-3 in all studied rheumatic diseases: rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus in comparison to the healthy subjects. This evidence concerns the gene LGALS3 and systemic sclerosis.